NCT05754138

Brief Summary

A multicenter observational study designed specifically to collect data on the safety of sport activities in patients with implanted S-ICD systems.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
32mo left

Started Feb 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress55%
Feb 2023Jan 2029

Study Start

First participant enrolled

February 1, 2023

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

February 11, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

March 3, 2023

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2029

Expected
Last Updated

March 3, 2023

Status Verified

February 1, 2023

Enrollment Period

2.9 years

First QC Date

February 11, 2023

Last Update Submit

February 21, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Tachyarrhythmia-related death or externally resuscitated cardiac arrest due to S-ICD

    Quantitative data will be reported by S-ICD interrogation including shock failure, incessant ventricular arrhythmia, or post-shock pulseless electrical activity.

    5 years

Secondary Outcomes (1)

  • S-ICD Lead fracture/malfunction

    5 years

Study Arms (1)

study population

The study population will consist of patients with an implanted S-ICD as their first implanted device, who continue to exercise regularly and actively participate in competitive or recreational sports with a sport-intensity above a predefined level

Device: Sport SICD

Interventions

Follow up

study population

Eligibility Criteria

Age10 Years - 60 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

patients with an implanted S-ICD as their first implanted device, who continue to exercise regularly and actively participate in competitive or recreational sports with a sport-intensity above a predefined level

You may qualify if:

  • Patient (male or female) is \<60 years of age.
  • Patient has an implanted with a new-generation S-ICD \[Boston Scientific EMBLEM, Generations 2 (model A209), 3 (A219) or newer\].
  • Present device is the first defibrillator implanted.
  • Patient has a functioning LATITUDE™ Home-Monitoring-System at home, knows how to use it and sends weekly reports via the home-monitoring system.
  • Patient actively participates in sport activities above a predefined level of exercise (see below).
  • Patient understands that, at present, there is virtually no data on the safety of sport participation for patients with implanted S-ICD system, particularly regarding potential damage caused by sport activities to the S-ICD system, including the subcutaneous electrode.
  • Patient understands that the level of sport activity, type of sport and frequency of exercise activities are entirely at his/her own discretion and responsibility.
  • Patient understands that The Sport S-ICD Study investigator neither encourage nor discourage performance of any given sport.
  • Patient understands that The Sport S-ICD Study is not liable for- and does assume any responsibility for any damages caused by sport participation to the implanted system or the health of patients participating in the study.
  • Patient is willing to provide informed consent to participate in the SPORT S-ICD Study. Informed consent includes agreement to provide all the following information:
  • Clinical data (age, gender, clinical diagnosis, indication for S-ICD implantation, arrhythmic events since S-ICD implantation, adverse events since S-ICD implantation)
  • Information concerning endpoint events during follow-up.

You may not qualify if:

  • Subjects with an inability to communicate well with the investigators.
  • Subjects who are non-cooperative or unwilling to sign consent form.
  • Evidence suggestive of malfunction of the implanted S-ICD system (like abnormal impedance or detected noise) at the time of screening

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tel Aviv Medical Center

Tel Aviv, Israel

RECRUITING

Central Study Contacts

Ehud Chorin, Dr

CONTACT

Sami Viskin, Prof

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Deputy director general for R&D

Study Record Dates

First Submitted

February 11, 2023

First Posted

March 3, 2023

Study Start

February 1, 2023

Primary Completion

January 1, 2026

Study Completion (Estimated)

January 1, 2029

Last Updated

March 3, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations